Patient characteristics and percentage of CD138+ cells after isolation using CD138 microbeads by MACS
Case . | Age, y/sex . | Subtype . | Stage . | CD138+ cells, % . | N-Ras mutation . |
|---|---|---|---|---|---|
| 1 | 67/M | IgA-κ | IIIA | 92 | — |
| 2 | 61/M | IgA-λ | IIIA | 90 | — |
| 3 | 75/M | IgA-λ | IIIA | 89 | — |
| 4 | 70/M | IgA-λ | IIIA | 96 | — |
| 5 | 68/F | IgG-λ | IIA | 82 | + (codon 6I CAA > CAG) |
| 6 | 52/F | IgG-κ | IIIA | 75 | — |
| 7 | 52/M | IgG-λ | PCL | 91 | — |
| 8 | 70/M | IgG-κ | IIA | 80 | — |
| 9 | 74/M | IgA-λ | IIIA | 70 | — |
| 10 | 68/F | IgA-κ | IIA | 86 | — |
Case . | Age, y/sex . | Subtype . | Stage . | CD138+ cells, % . | N-Ras mutation . |
|---|---|---|---|---|---|
| 1 | 67/M | IgA-κ | IIIA | 92 | — |
| 2 | 61/M | IgA-λ | IIIA | 90 | — |
| 3 | 75/M | IgA-λ | IIIA | 89 | — |
| 4 | 70/M | IgA-λ | IIIA | 96 | — |
| 5 | 68/F | IgG-λ | IIA | 82 | + (codon 6I CAA > CAG) |
| 6 | 52/F | IgG-κ | IIIA | 75 | — |
| 7 | 52/M | IgG-λ | PCL | 91 | — |
| 8 | 70/M | IgG-κ | IIA | 80 | — |
| 9 | 74/M | IgA-λ | IIIA | 70 | — |
| 10 | 68/F | IgA-κ | IIA | 86 | — |
M indicates male; F, female; PCL, plasma cell leukemia.